Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 1998
- Founded
Key Decision Makers
Johan Drott
CEO
Karin Wehlin
Chairman of the Board
Kristina Drott
Board member
Mia Lundblad
Board member
Description
Respiratorius AB (publ) is a specialized biotechnology company focused on developing novel drug candidates for treating aggressive cancers. Their primary mission is to reduce the global burden of aggressive lymphoma, particularly Diffuse large B-cell lymphoma (DLBCL). The company bases its drug cand...